Percheron Therapeutics LimitedASX: PER

ANP meeting with US FDA granted for ATL1102 in DMD

Feb 15, 2021 at 3:25 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment